Improving Hepatitis B Screening Prior to Rituximab: A Quality Improvement Project

Rituximab, used in the treatment of some rheumatic and kidney diseases, can lead to hepatitis B virus (HBV) reactivation; HBV screening is recommended for those starting this medication. We aimed to improve by 50% the proportion of patients undergoing HBV screening by implementing multimodal interve...

Descripción completa

Detalles Bibliográficos
Autores principales: Villacis-Nunez, D. Sofia, Orenstein, Evan, Selvaggio, Phyllis, Rouster-Stevens, Kelly, Wang, Chia-shi, Thakral, Amit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378200/
https://www.ncbi.nlm.nih.gov/pubmed/37508639
http://dx.doi.org/10.3390/children10071142

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378200/
https://www.ncbi.nlm.nih.gov/pubmed/37508639
http://dx.doi.org/10.3390/children10071142

Ejemplares similares